Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
A judge said Friday that he planned to approve a deal for OxyContin maker Purdue Pharma and members of the Sackler family who own the company to settle thousands of lawsuits over the toll of opioids, allowing money to start flowing to victims as…
News Wrap: Bankruptcy court will approve Purdue Pharma's opioid settlement
In the day's other headlines: A federal judge says he will approve Purdue Pharma's latest deal to settle thousands of opioid-related lawsuits. The agreement would require the Sackler family to contribute up to $7 billion over 15 years to state and…
Purdue Pharma Gets Court Nod for Bankruptcy Exit, Sackler Deal
Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar settlement and liability releases for the opioid manufacturer's Sackler family owners. Judge Sean H. Lane said he will sign off…
Bankruptcy judge green lights $7.4bn Purdue Pharma settlement - BBC News
A bankruptcy judge on Friday said he would sign off on a deal that forces Purdue Pharma and its billionaire owners to pay out $7.4bn (£5.6bn) over the OxyContin maker's role in the US opioid crisis. Approval of the plan, which was first…
Judge says he'll approve opioid settlement with Purdue Pharma and Sackler family
NEW YORK (AP) — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the…
US judge to approve Purdue Pharma's opioid bankruptcy settlement
A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S. opioid epidemic through the sale of addictive pain…
US bankruptcy court to approve deal with Purdue Pharma and Sackler family
A federal bankruptcy court judge has said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids. Friday's deal, overseen by United States Bankruptcy Judge Sean Lane, would require…
Purdue Pharma opioid settlement, bankruptcy deal to get U.S. judge approval - National
A federal bankruptcy court judge on Friday said he will approve OxyContin -maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic. The deal…
Purdue Pharma's $7B opioid bankruptcy deal to settle thousands of lawsuits gets green light
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic. The deal…
Judge says he'll approve Purdue Pharma's new $7B opioid settlement with the Sacklers
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic. The deal…
Natco Pharma's Q2 net down 23% at ₹518 cr
Natco Pharma's consolidated net profit declined 23 per cent at ₹518 crore in the second quarter of the current financial year ended September 30, 2025 compared to ₹676 crore in the corresponding quarter of previous financial year. The…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Issues Earnings Results, Beats Estimates By $0.21 EPS
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.90) earnings per share for the quarter, beating the consensus estimate of ($1.11) by $0.21, Zacks reports. The…
Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX
Monetta Financial Services Inc. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 30,000 shares of the biopharmaceutical…
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Microsoft (NASDAQ:MSFT), Enanta Pharma (NASDAQ:ENTA)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst William Power initiated…
Bankruptcy judge OK's $7.4 billion OxyContin settlement
Nov. 14 (UPI) -- OxyContin-maker Purdue Pharma can settle claims against it by paying up to $7.4 billion to end cases filed amid the nation's opioid epidemic, a federal bankruptcy judge ruled Friday. The proposed settlement is $1 billion more than…
Receive a Daily briefing on Pharma Industry News
Get Started